A hybrid BiLSTM transformer model for drug synergy prediction
Accurately predicting synergistic drug combinations remains a critical challenge in computational pharmacology, with important implications for the development of combination therapies in oncology. However, in vitro screening of drug combinations for synergy is both time-consuming and labor-intensive, as the number of...